Relationship between cathepsin-D and other prognostic factors in human breast cancer

Tumori

Volumn 83, Issue 3, 1997, Pages 685-688

  Glikman, Patricia ^a   Rogozinski, Amelia ^a   Mosto, Julian ^a   Pollina, Angelica ^a   Garbovesky, Carlos ^b   Levy, Carlos ^a  

^a HOSPITAL RAMOS MEJÍA   (Argentina)

^b Hospital Maria Curie   (Argentina)

Author keywords

breast cancer; cathepsin D; nodal status; prognostic factors

Indexed keywords

CATHEPSIN D;

ADULT; AGED; ARTICLE; BREAST CANCER; CYTOSOL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS;

EID: 0030874345     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300312     Document Type: Article

References (35)

1. Alexieva-Figusch J., Van Putten W.L.J., Blankenstein M.A., Blonk-Van Der Wijst J., Klijn J.G.M.: The prognostic value and relationships of patient characteristics, estrogen and progestin receptors and site of relapse in primary breast cancer. Cancer, 61: 758-768, 1988.
2. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem., 72: 248-254, 1976.
3. Cazin J.L., Gosselin P., Boniface B., Boniface M., Demaille A.: Expression of pS2 and cathepsin D in breast cancer. Int. J. Oncol., 2: 1081-1084, 1993.
4. Clark G.M., Mc Guire W.L., Hubay C.A., Pearson O.H., Marshall J.S.: Progesterone receptors as a prognostic factor in stage II breast cancer. N. Engl. J. Med., 309: 1343-1347, 1983.
5. Duffy M.J., Broillet J-P., Reilly D., Mc Dermott E., O'Higgins N., Fennelly J., Maudelonde T., Rochefort H.: Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological and clinical findings. Clin. Chem., 37: 101-104, 1991.
6. Edwards D.D.P., Chamness G.C., Mc Guire W.L.: Estrogen and progesteron receptors in breast cancer. Biochim. Biophys. Acta, 560: 457-486, 1979.
7. Foekens J.A., Van Putten W.L.J., Portengen H., Koning H.Y.W.C.M., Thirion B., Alexieva-Figusch J., Klijn J.G.M.: Prognostic value of pS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J. Clin. Oncol., 11: 899-908, 1993.
8. Gion M., Mione R., Dittadi R., Romanelli M., Pappagallo L., Capitanio G., Friede U., Barbazza R., Visona A., Dante S.: Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur. J. Cancer, 31 A: 671-677, 1995.
9. Glikman P., Vegh I., Pollina M.A. Mosto A.H., Levy C.M.: Ornythine decarboxylase activity, prolactin blood levels and estradiol and progesterone receptors in human breast cancer. Cancer, 60: 2237-2243, 1987.
10. Granata G., Coradini D., Cappelletti V., Di Fronzo G.: Prognostic relevance of cathepsin-D versus oestrogen receptors in node negative breast cancer. Eur. J. Cancer, 27: 970-972, 1991.
11. Horwitz K.B., McGuire W.L., Pearson O.H., Segaloff A.: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science, 189: 726-727, 1975.
12. Horwitz K.B., Wei L.L., Seedlacek S.M., D'Arveille C.N.: Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog. Horm. Res., 41: 249-316, 1985.
13. Knight W.A., Livingston R.B., Gregory E.J., Mc Guire W.L.: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res., 37: 4669-4671, 1977.
14. Letto G., Gebbia N., Rama L., Tumminello P.M.: Cathepsin D in the malignant progression of neoplastic disease (review). Anticancer Res., 12: 235-240, 1992.
15. Marsigliante S., Biscozzo L., Greco S., Leo G., Storelli C.: Relation of cathepsin D level to the estrogen receptor in human breast cancer. Int. J. Clin. Lab. Res., 22: 52-57, 1992.
16. Maudelonde T., Khalaf S., Garcia M., Freiss G., Duporte J., Benatia M., Rogier H., Paolucci F., Simony J., Pujol H., Pau B., Rochefort H.: Immunoenzymatic assay of Mr 52,000 cathepsin-D in 182 breast cancer cytosols. Low correlation with other prognostic parameters. Cancer Res., 48: 462-466, 1988.
17. Mc Guire W.L., De La Garza M., Chamnes G.C.: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res., 37: 637-639, 1977.
18. Montcourrier P., Mangeat P.H., Salazar G., Morisset M., Sahuquet A., Rochefort H.: Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res., 50: 6045-6054, 1990.
19. Namer M., Ramaioli A., Fontana X., Etienne M.C., Hery M., Jourlait A., Milano G., Frenay M., Francois E., Lapalus F.: Prognostic value of total cathepsin-D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res. Treat. 19: 85-93, 1991.
20. Pichon M.F., Milgrom E.: Characterization and assay of progesterone receptor in human mammary carcinoma. Cancer Res., 37:464-471, 1977.
21. Pujol P., Maudelonde T., Daures J-P., Rouanet P., Brouillet J-P., Pujol H., Rochefort H.: A perspective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer, 71: 2006-2012, 1993.
22. Rochefort H., Capony F., Garcia M., Cavailles V., Freiss G., Chambon M., Morisset M., Vignon F.: Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J. Cell. Biochem., 35: 17-29, 1987.
23. Rochefort H., Augereau P., Briozzo P., Capony F., Cavailles V., Freiss G., Garcia M., Maudelonde T., Morisset M., Vignon F.: Structure, function, regulation and clinical significance of the 52 K pro-cathepsin D secreted by breast cancer cells. Biochimie, 70: 943-949, 1988.
24. Rochefort H.: Biological and clinical significance of Cathepsin-D in breast cancer. Acta Oncol., 31: 125-130, 1992.
25. Rochefort H.: Cathepsin-D in breast cancer; a tissue marker associated with metastasis. Eur. J. Cancer, 28 A: 1780-1783, 1992.
26. Romain S., Muracciole X., Varette I., Bressac C., Brandone H., Martin P.M.: La cathepsine-D: un facteur pronostique independant dans la cancer du sein. Bull. Cancer, 77: 439-447, 1990.
27. Schultz D.C., Shamideh B., Wright L.M., Tucker S., Lange M.K., Tachevsky T., Longo S., Niedbaala S., Alhadeff J.A.: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Cancer Res., 54: 48-54, 1994.
28. Shaheen R.M., Miseljic S., Whiele R.D., Wittliff J.L. Relation between cathepsin D expression and other prognostic factors in breast carcinomas. Clin. Chem., 41: 1585-1591, 1995.
29. Silvestrini R., Daidone M.G., Valagusa P., Salvadori B., Rovini D., Bonadonna G.: Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treat. Rep., 71: 375-379, 1987.
30. Spyratos F., Brouillet J-P., De Frenne A., Hacene K., Rouesse J., Maudelonde T., Brunet M., Andrid C., Desplaces A., Rochefort H.: Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet, I: 1115-1118, 1989.
31. Tandon A.K., Clark J.M., Chamness G.C., Chirgwin J.M., Mc Guire W.L.: Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 332: 297-302, 1990.
32. Thorpe S., Rochefort H., Garcia M., Freiss G., Christensen I.J., Khalaf S., Paolucci F., Pau B., Rasmussen B.B., Rose C. Association between high concentration of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res., 49: 6008-6014, 1989.
33. Tubiana M., Pejovic M., Chavandra N.: The long term prognostic significance of the thymidine labeling index on breast cancer. Int. J. Cancer, 33: 441-445, 1985.
34. Westley B.R., Rochefort H.: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20: 353-362, 1980.
35. Westley B.R., May F.E.B.: Oestrogen regulates cathepsin D mRNA levels in estrogen responsive human breast cancer cells. Nucleic Acids Res., 15: 3773-3786, 1987.